Katherine R. Tuttle, MD, FASN, FACP, FNKF, a nephrologist from the University of Washington and Providence Health Care, discussed new consensus guidelines that call for the early use of SGLT2 inhibitors, GLP-1 receptor agonists, and finerenone in the care of …